Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease

Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease

Date / Time:

23/05/2017

Location:

SMALL LECTURE THEATRE, Sherrington Building

Cerebrospinal and serum alpha-synuclein species as potential biomarkers for Parkinson’s disease

Prof. El-Agnaf is considered a pioneer in the field of Parkinson’s disease and related disorders. Several inventions have emerged from his research, and his discoveries have greatly impacted the scientific research community, provided further insight into the molecular pathogenesis of Parkinson’s disease, and offered new opportunities for the development of novel diagnostic and therapeutic tools for Parkinson’s disease. His research has also been translated into clinical studies to evaluate the potential use of α-synuclein in body fluids as diagnostic marker for Parkinson’s disease and related disorders. MORE INFO.

A group of scientists led by Dr. Abdelilah Arredouani from the Diabetes Research Center at the Qatar Biomedical Research Institute (QBRI), a research institute of Hamad bin Khalifa University (HBKU)...